Genetic and environmental nature of the insulin resistance syndrome in Indo-Mauritian subjects with premature coronary heart disease: Contribution of β3-adrenoreceptor gene polymorphism and beta blockers on triglyceride and HDL concentrations

Diabetologia

Volumn 44, Issue 1, 2001, Pages 115-122

  Manraj, M ^a   Francke, S ^c   Hebe A ^a   Ramjuttun, U S ^b   Froguel, P ^c  

^a UNIVERSITY OF MAURITIUS   (Mauritius)

^b Ministry of Health   (Mauritius)

^c INSTITUT PASTEUR DE LILLE   (France)

Author keywords

3 adrenergic receptor polymorphism; Beta blocker; CHD; HDL cholesterol; Indo Mauritian population; Insulin resistance; Triglyceride concentration; Type II diabetes mellitus

Indexed keywords

ARGININE; BETA 3 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL; TRYPTOPHAN;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DRUG EFFECT; DYSLIPIDEMIA; ENVIRONMENTAL FACTOR; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HEREDITY; HUMAN; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MAURITIUS; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR;

ADRENERGIC BETA-ANTAGONISTS; ADULT; ALBUMINURIA; BODY CONSTITUTION; BODY MASS INDEX; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; CORONARY DISEASE; ENVIRONMENT; FEMALE; HUMANS; HYPERTENSION; INSULIN RESISTANCE; LIPIDS; MALE; MAURITIUS; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, ADRENERGIC, BETA-3; RISK FACTORS; SYNDROME; TRIGLYCERIDES;

EID: 0035128708     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051588     Document Type: Article

References (30)

1. Coronary heart disease in south Asians overseas: A review
2. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians
3. Is hyperinsulinemia a central characteristic of a chronic cardiovascular risk factor clustering syndrome? Mixed findings in Asian, Creole and Chinese Mauritians
4. Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene
5. 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns
6. Genetic variation in the Beta-3 adrenergic-receptor and an increased capacity to gain weight in patients with morbid obesity
7. A paired sibling analysis of the Beta-3 Adrenergic Receptor and obesity in Mexican Americans
8. 3-adrenoreceptor gene polymorphism: A newly identified risk factor for proliferative retinopathy in NIDDM patients
9. Recommendations guiding physicians in biomedical research involving human subjects
10. Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man
11. The Metabolic Syndrome
12. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: Studies in subjects with various degrees of glucose tolerance and insulin sensitivity
13. Induction of insulin resistance by beta-blocker treatment but not ACE-inhibition: Long term treatment with atenolol or trandolapril
14. Effects of doxazosin and atenolol on atherothrombogenic risk profile in hypertensive middle-aged men
15. Plasma HDL cholesterol, triglycerides and adiposity. A quantitative genetic test of the conjoint trait hypothesis in the San Antonio Family Heart Study
16. Effect of physical activity on lipid levels in a population-based sample of men with and without the Arg192 variant of the human paraoxonase gene
17. β3-Adrenergic-receptor polymorphism: A genetic marker for visceral fat obesity and the insulin resistance syndrome
18. The Trp64Arg polymorphism of the beta3-adrenergic receptor gene and obesity in Chinese subjects with components of the metabolic syndrome
19. A pathogenic role of visceral fat beta3-adrenoceptors in obesity
20. The metabolic syndrome is related to beta3-adrenoceptor sensitivity in visceral adipose tissue
21. New insights into sympathetic regulation of glucose and fat metabolism
22. Mutations and diseases of G protein coupled receptors
23. Pharmacological characterization of a recently described human beta3-adrenergic receptor mutant
24. Phenotypic characterization of the Trp64Arg polymorphism in the beta3-adrenergic receptor gene in normal weight and obese subjects
25. No effect of the Trp64Arg β3-adrenoceptor variant on in vivo lipolysis in subcutaneous adipose tissue
26. β3-Adrenergic receptor variant and lipid metabolism in Pima Indians
27. Tissue distribution of β3 adrenergic receptor mRNA in man
28. Lack of β3-adrenergic effect on lipolysis in human subcutaneous adipose tissue
29. Trp64Arg mutation of beta3-adrenoceptor gene deteriorates lipolysis induced by beta3-adrenoceptor agonist in human omental adipocytes
30. Mutated human beta3-adrenergic receptor (Trp64Arg) lowers the response to beta3-adrenergic agonists in transfected 3T3-L1 preadipocytes